South African tycoon Stephen Saad’s Aspen turns menopause drug rights into a $220 million deal
African Insider | 03.11.2026 14:00Cape Town – South African billionaire Stephen Saad’s pharmaceutical company, Aspen Pharmacare, has agreed to sell the European rights to its menopause treatment, Ovestin, for €197 million (approximately $220 million or R3.7 billion) as it continues restructuring its international operations.
